Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis

References

• Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg. 2013;39:1745–1757. doi:10.1111/dsu.1234624299571
   PubMed Web of Science ®Google Scholar
• Hardy MA. The biology of scar formation. Phys Ther. 1989;69:1014–1024. doi:10.1093/ptj/69.12.10142479956
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Bai X, Li Y, Shi J, Hu D. Recent advances in hypertrophic scar. Histol Histopathol. 2018;33:27–39. doi:10.14670/HH-11-90828560711
   PubMed Web of Science ®Google Scholar
• Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435–1458.10513931
   PubMed Web of Science ®Google Scholar
• Rabello FB, Souza CD, Farina JJ. Update on hypertrophic scar treatment. Clinics (Sao Paulo). 2014;69:565–573. doi:10.6061/clinics/2014(08)1125141117
   PubMed Web of Science ®Google Scholar
• Steinstraesser L, Flak E, Witte B, et al. Pressure garment therapy alone and in combination with silicone for the prevention of hypertrophic scarring: randomized controlled trial with intraindividual comparison. Plast Reconstr Surg. 2011;128:306e–313e. doi:10.1097/PRS.0b013e3182268c69
   PubMed Web of Science ®Google Scholar
• Sheridan RL. Burn care: results of technical and organizational progress. JAMA. 2003;290:719–722. doi:10.1001/jama.290.6.71912915409
   PubMed Web of Science ®Google Scholar
• Moulin, V., Larochelle S, Langlois C et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004;198:350–358. doi:10.1002/jcp.1041514755540
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu Z, Cao W, et al. Amentoflavone inhibits angiogenesis of endothelial cells and stimulates apoptosis in hypertrophic scar fibroblasts. Burns. 2014;40:922–929. doi:10.1016/j.burns.2013.10.01224280521
   PubMedGoogle Scholar
• Shi J, Xiao H, Li J, et al. Wild-type p53-modulated autophagy and autophagic fibroblast apoptosis inhibit hypertrophic scar formation. Lab Invest. A J Tech Methods and Pathology. 2018;98(11):1423–1437.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xie Y, Xiao H, et al. MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7. Biomedicine & pharmacotherapy = Biomedicine & Pharmacotherapie. Apr 2018;100:184–190.
   Google Scholar
• Yang Q, Wang Y, Yang Q, et al. Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer. Biomaterials. 2017;146:72–85. doi:10.1016/j.biomaterials.2017.09.00828898759
   PubMedGoogle Scholar
• Hu Y, Wang Y. Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells. Int J Nanomed. 2641 2012;7:2641–52. doi: 10.2147/IJN.S31133.
   PubMedGoogle Scholar
• Sankar R, Baskaran A, Shivashangari KS, Ravikumar V. Inhibition of pathogenic bacterial growth on excision wound by green synthesized copper oxide nanoparticles leads to accelerated wound healing activity in Wistar Albino rats. J Mater Sci Mater Med. 2015;26:214. doi:10.1007/s10856-015-5543-y26194977
   PubMed Web of Science ®Google Scholar
• Borkow G, Gabbay J, Dardik R, et al. Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings. Wound Repair Regen. 2010;18:266–275. doi:10.1111/j.1524-475X.2010.00573.x20409151
   PubMed Web of Science ®Google Scholar
• Wang Y, Zi X-Y, Su J, et al. Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells. Int J Nanomedicine. 2012;7:2641–2652. doi:10.2147/IJN.S3113322679374
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang F, Zhang H-X, et al. Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death Dis. 2013;4:e783. doi:10.1038/cddis.2013.31423990023
   PubMed Web of Science ®Google Scholar
• Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg. 1997;100:674–681.9283567
   PubMed Web of Science ®Google Scholar
• Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–1252. doi:10.1016/j.cell.2006.06.01016814712
   PubMed Web of Science ®Google Scholar
• Duchen MR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med. 2004;25:365–451. doi:10.1016/j.mam.2004.03.00115302203
   PubMedGoogle Scholar
• Huttemann M, Lee I, Pecinova A, Pecina P, Przyklenk K, Doan JW. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J Bioenerg Biomembr. 2008;40:445–456. doi:10.1007/s10863-008-9169-318843528
   PubMed Web of Science ®Google Scholar
• Rai NK, Tripathi K, Sharma D, Shukla VK. Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds. 2005;4:138–144. doi:10.1177/153473460528001816100094
   PubMedGoogle Scholar
• Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol. 1997;29:19–30.9076938
   PubMed Web of Science ®Google Scholar
• Lagares, D., Santos A, Grasberger PE, et al. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. Sci Transl Med. 2017;9. doi:10.1126/scitranslmed.aal3765
   PubMed Web of Science ®Google Scholar
• Mohammadinejad, R., Moosavi MA, Tavakol S, et al. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles. Autophagy Jan 2019;15(1):4–33.
   Google Scholar
• Wang Y, Yang Q-W, Yang Q, et al. Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway. Int J Nanomedicine2017;12:2569–2579. doi:10.2147/IJN.S130537
   Google Scholar
• Campbell KJ, Tait S. Targeting BCL-2 regulated apoptosis in cancer. Open Biol. 2018;8. doi:10.1098/rsob.180002
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312. doi:10.1126/science.281.5381.13099721092
   PubMed Web of Science ®Google Scholar
• Hockenbery DM, Giedt CD, O’Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res. 2002;85:203–242.12374287
   PubMed Web of Science ®Google Scholar
• Singh KK. Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci. 2006;1067:182–190. doi:10.1196/annals.1354.02216803984
   PubMed Web of Science ®Google Scholar
• Sinha N, Panda PK, Naik PP, et al. Abrus agglutinin promotes irreparable DNA damage by triggering ROS generation followed by ATM-p73 mediated apoptosis in oral squamous cell carcinoma. Mol Carcinog. 2017;56:2400–2413. doi:10.1002/mc.2267928543759
   PubMedGoogle Scholar
• Mos quera J, Garcia I, Liz-Marzan LM. Cellular uptake of nanoparticles versus small molecules: a matter of size. Acc Chem Res. 18 Sep 2018;51(9):2035–2313.
   Web of Science ®Google Scholar
• Li Z, Tang S, Wang B, et al. Metabolizable small gold nanorods: size-dependent cytotoxicity, cell uptake and in vivo biodistribution. ACS Biomaterials Science & Engineering. 2016 2016;2(5):789–797.
   Web of Science ®Google Scholar
• Zhang X, Luo Z, Chen J, et al. Storage of gold nanoclusters in muscle leads to their biphasic in vivo clearance. Small. 2015;11:1683–1690. doi:10.1002/smll.20140223325408470
   PubMedGoogle Scholar
• Cho W, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236:16–24. doi:10.1016/j.taap.2008.12.02319162059
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134:2139–2147.22191645
   PubMed Web of Science ®Google Scholar
• Song Y, Yu Z, Song B, et al. Usnic acid inhibits hypertrophic scarring in a rabbit ear model by suppressing scar tissue angiogenesis. Biomed Pharmacother. 2018;108:524–530. doi:10.1016/j.biopha.2018.06.17630243085
   PubMedGoogle Scholar
• Wang J, Chen H, Shankowsky HA, Scott PG, Tredget EE. Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res. 2008;28:423–434. doi:10.1089/jir.2007.010418597619
   PubMedGoogle Scholar
• Song H, Wang W, Zhao P, Qi Z, Zhao S. Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. Nanoscale. 2014;6:3206. doi:10.1039/c3nr04363k24499922
   PubMed Web of Science ®Google Scholar